Doxorubicin-resistant chronic myeloid leukemia cells enhanced phosphorylation of STAT3 and dampened the tumor growth inhibition of TNF-α. This evidence concerns the gene STAT3 and chronic myelogenous leukemia, BCR-ABL1 positive.